Central NY Clinical Research is categorized under Medical Labs in Manlius, NY and active since 2007.
Central NY Clinical Research was established in 2007, and today employs 1 to 4, earning Unknown per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact Renee Barbato, Executive Director at the company’s single location by writing to 4500 Pewter Lane, Manlius, New York NY 13104 or by phoning (315) 682-3263. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central NY Clinical Research |
| Contact Person: | Renee Barbato, Executive Director |
| Address: | 4500 Pewter Lane, Manlius, New York 13104 |
| Phone Number: | (315) 682-3263 |
| Website Address: | cnycr.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 5417115 |
| Share This Business: |
Central NY Clinical Research was started in 2007 to provide professional Medical Labs under the SIC code 8071 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Renee Barbato, Executive Director for inquiries that concern Central NY Clinical Research by calling the company number (315) 682-3263, as your correspondence is most welcome. Additionally, the physical location of the single location of Central NY Clinical Research can be found at the coordinates 42.992585,-75.95609 as well as the street address 4500 Pewter Lane in Manlius, New York 13104.
For its online presence, you may visit Central NY Clinical Research’s website at cnycr.com and engage with its social media outlets through on Twitter and on Facebook.